Old Web
English
Sign In
Acemap
>
authorDetail
>
John Mark Barnett
John Mark Barnett
Medicine
Pathology
Cancer
Internal medicine
Oncology
4
Papers
101
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of milciclib (PHA-848125AC), a pan-cyclin d-dependent kinase inhibitor, in two phase II studies with thymic carcinoma (TC) and B3 thymoma (B3T) patients.
2018
Journal of Clinical Oncology
Benjamin Besse
Marina Chiara Garassino
Arun Rajan
Silvia Novello
Julien Mazieres
Glen J. Weiss
Darren M. Kocs
John Mark Barnett
Cristina Davite
Patrizia Crivori
Giuseppe Giaccone
Show All
Source
Cite
Save
Citations (14)
Multidetector computed tomography pulmonary angiography: does arm position affect pulmonary artery enhancement?
2008
Journal of Computer Assisted Tomography
Martin L. Gunn
Adam Worthington
Damien Hoon
John Mark Barnett
C. Craig Blackmore
Show All
Source
Cite
Save
Citations (0)
Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.
2005
American Journal of Clinical Oncology
James Y. Tsai
David A. Iannitti
Anna Berkenblit
Paul A. Akerman
A. Nadeem
Ritesh Rathore
David T. Harrington
Dean Roye
Thomas J. Miner
John Mark Barnett
Christine Maia
Keith Stuart
Howard Safran
Show All
Source
Cite
Save
Citations (9)
Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study.
2005
American Journal of Clinical Oncology
David A. Iannitti
T.A. DiPetrillo
Paul A. Akerman
John Mark Barnett
Christine Maia-acuna
Dennis Cruff
Tom Miner
Diane Martel
William G. Cioffi
Melissa Remis
Teresa Kennedy
Howard Safran
Show All
Source
Cite
Save
Citations (78)
1